Last reviewed · How we verify
Atherosclerosis
Approved treatments
- Praluent · Sanofi
Praluent blocks the PCSK9 protein, which helps remove LDL cholesterol from the bloodstream, thereby reducing cholesterol levels. - Colcrys · Scilex Pharms
Colcrys works by inhibiting the activity of a specific enzyme called serine/threonine-protein kinase pim-1. - Praluent · Regeneron Pharmaceuticals
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Atherosclerosis patent landscape — cliff calendar, originator estates, attackable patents
- Atherosclerosis treatment landscape brief
- Atherosclerosis treatment updates RSS
Frequently asked questions about Atherosclerosis
What drugs treat Atherosclerosis?
Tracked treatments include Praluent, Colcrys.
What is the treatment for Atherosclerosis?
Standard treatment for Atherosclerosis includes Praluent, Colcrys. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Atherosclerosis patent cliff · Atherosclerosis CI report
- Treatment: Praluent · Sanofi
- Treatment: Colcrys · Scilex Pharms
- Treatment: Praluent · Regeneron Pharmaceuticals
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing